The effect of beta-cyclodextrin on percutaneous absorption of commonly used Eusolex® sunscreens

Drug Research

Volumn 63, Issue 11, 2013, Pages 591-596

  Shokri, J ^b   Hasanzadeh, D ^b   Ghanbarzadeh, S ^b   Dizadji Ilkhchi, M ^b   Adibkia, K ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

complexation; Eusolex 9020; Eusolex 232; Eusolex 4360; percutaneous absorption; sunscreen

Indexed keywords

AVOBENZONE; BETA CYCLODEXTRIN; ENSULIZOLE; EUSOLEX 9020; OXYBENZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG MIXTURE; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LAG; MALE; NONHUMAN; RAT; SKIN ABSORPTION; SKIN PENETRATION; SKIN PERMEABILITY; TIME; ULTRAVIOLET RADIATION;

ANIMALS; BENZIMIDAZOLES; BENZOPHENONES; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; MALE; RATS; RATS, WISTAR; SKIN ABSORPTION; SULFONIC ACIDS; SUNSCREENING AGENTS;

EID: 84888873876     PISSN: 21949379     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0033-1349089     Document Type: Article

References (43)

1. Botta C., Di Giorgio C., Sabatier A-S et al. Genotoxicity of visible light (400-800 nm) and photoprotection assessment of ectoin, l-ergothioneine and mannitol and four sunscreens. J Photochem Photobiol B: Biol: 2008; 91 24 34 (Pubitemid 351494452)
2. Brausch J. M., Rand G. M. A review of personal care products in the aquatic environment: Environmental concentrations and toxicity. Chemosphere: 2011; 82 1518 1532
3. Chetelat A., Dresp J. H., Gocke E. Photomutagenesis test development: II. 8-methoxypsoralen, chlorpromazine and sunscreen compounds in chromosomal aberration assays using CHO cells. Mutation Research/Environmental Mutagenesis and Related Subjects. 1993; 292 251 258
4. Crovara Pescia A., Astolfi P., Puglia C. et al. On the assessment of photostability of sunscreens exposed to UVA irradiation: From glass plates to pig/human skin, which is best? Int J Pharm: 2012; 427 217 223
5. Gaspar L. R., Campos PMBG M. Photostability and efficacy studies of topical formulations containing UV-filters combination and vitamins A, C and E. Int J Pharm: 2007; 343 181 189 (Pubitemid 47321928)
6. Gonzalez S., Fernandez-Lorente M., Gilaberte-Calzada Y. The latest on skin photoprotection. Clin Dermatol: 2008; 26 614 626
7. Couteau C., Couteau O., Alami-El Boury S. et al. Sunscreen products: What do they protect us from? Int J Pharm: 2011; 415 181 184
8. Einspahr J. G., Stratton S. P., Bowden G. T. et al. Chemoprevention of human skin cancer. Crit Rev Oncol Hematol: 2002; 41 269 285 (Pubitemid 34203664)
9. Gaspar L. R., Maia Campos PMB G. Evaluation of the photostability of different UV filter combinations in a sunscreen. Int J Pharm: 2006; 307 123 128 (Pubitemid 41820404)
10. Kullavanijaya P., Lim HW. Photoprotection. J Am Acad Dermatol: 2005; 52 937 958
11. Nikolic S., Keck C. M., Anselmi C. et al. Skin photoprotection improvement: Synergistic interaction between lipid nanoparticles and organic UV filters. Int J Pharm: 2011; 414 276 284
12. Pathak M. A. Sunscreens: Topical and systemic approaches for protection of human skin against harmful effects of solar radiation. J Am Acad Dermatol: 1982; 7 285 312
13. Sambandan D. R., Ratner D. Sunscreens: An overview and update. J Am Acad Dermatol: 2011; 64 748 758
14. Schaefer H., Moyal D., Fourtanier A. Recent advances in sun protection. Semin Cutan Med Surg: 1998; 17 266 275 (Pubitemid 28555132)
15. Cal K., Centkowska K. Use of cyclodextrins in topical formulations: Practical aspects. Eur J Pharm Biopharm: 2008; 68 467 478 (Pubitemid 351318207)
16. Pardeike J., Hommoss A., Müller R. H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm: 2009; 366 170 184
17. Scalia S., Tursilli R., Bianchi A. et al. Incorporation of the sunscreen agent, octyl methoxycinnamate in a cellulosic fabric grafted with β-cyclodextrin. Int J Pharm: 2006; 308 155 159 (Pubitemid 43097247)
18. Scalia S., Villani S., Scatturin A. et al. Complexation of the sunscreen agent, butyl-methoxydibenzoylmethane, with hydroxypropyl-β-cyclodextrin. Int J Pharm: 1998; 175 205 213 (Pubitemid 28517976)
19. Touitou E., Godin B. Skin nonpenetrating sunscreens for cosmetic and pharmaceutical formulations. Clin Dermatol: 2008; 26 375 379
20. Wang S. Q., Tooley I. R. Photoprotection in the Era of Nanotechnology. Semin Cutan Med Surg: 2011; 30 210 213
21. Lopez-García M. A., Lopez O., Maya I. et al. Complexation of hydroxytyrosol with β-cyclodextrins. An efficient photoprotection. Tetrahedron: 2010; 66 8006 8011
22. Scalia S., Molinari A., Casolari A. et al. Complexation of the sunscreen agent, phenylbenzimidazole sulphonic acid with cyclodextrins: effect on stability and photo-induced free radical formation. Eur J Pharm Sci: 2004; 22 241 249 (Pubitemid 38758011)
23. Scalia S., Tursilli R., Iannuccelli V. Complexation of the sunscreen agent, 4-methylbenzylidene camphor with cyclodextrins: Effect on photostability and human stratum corneum penetration. J Pharm Biomed Anal: 2007; 44 29 34 (Pubitemid 46551575)
24. Hung C-F, Fang C-L, Al-Suwayeh S. A. et al. Evaluation of drug and sunscreen permeation via skin irradiated with UVA and UVB: Comparisons of normal skin and chronologically aged skin. J Dermatol Sci: 2012; 68 135 148
25. Molina-Molina J-M, Escande A., Pillon A. et al. Profiling of benzophenone derivatives using fish and human estrogen receptor-specific in vitro bioassays. Toxicol Appl Pharmacol: 2008; 232 384 395
26. Nash J. F. Human Safety and Efficacy of Ultraviolet Filters and Sunscreen Products. Dermatol Clin: 2006; 24 35 51 (Pubitemid 41741819)
27. Rhodes M. C., Bucher J. R., Peckham J. C. et al. Carcinogenesis studies of benzophenone in rats and mice. Food Chem Toxicol: 2007; 45 843 851 (Pubitemid 46452882)
28. Soeborg T., Ganderup N-C, Kristensen J. H. et al. Distribution of the UV filter 3-benzylidene camphor in rat following topical application. J Chromatogr B: 2006; 834 117 121
29. Nokhodchi A., Shokri J., Dashbolaghi A. et al. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm: 2003; 250 359 369 (Pubitemid 36084360)
30. Shokri J., Nokhodchi A., Dashbolaghi A. et al. The effect of surfactants on the skin penetration of diazepam. Int J Pharm: 2001; 228 99 107 (Pubitemid 32905369)
31. Javadzadeh Y., Shokri J., Hallaj-Nezhadi S. et al. Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants. Pharm Dev Technol: 2010; 15 619 625
32. Shokri J., Azarmi S., Hallaj-Nezhadi S. et al. Effects of various penetration enhancers on percutaneous absorption of piroxicam from emulgels. Research in Pharmaceutical Sciences: 2012; 7 225 234
33. Aigner Z., Berkesi O., Farkas G. et al. DSC, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding. J Pharm Biomed Anal: 2012; 57 62 67
34. Karadzovska D., Brooks J. D., Monteiro-Riviere N. A. et al. Predicting skin permeability from complex vehicles. Adv Drug Delivery Rev: 2012
35. Liu L., Zhu S. A study on the supramolecular structure of inclusion complex of β-cyclodextrin with prazosin hydrochloride. Carbohydr Polym: 2007; 68 472 476 (Pubitemid 46365946)
36. Marques HM C., Hadgraft J., Kellaway I. W. Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC. Int J Pharm: 1990; 63 259 266
37. Spada G., Gavini E., Cossu M. et al. Evaluation of the effect of hydroxypropyl-β-cyclodextrin on topical administration of milk thistle extract. Carbohydr Polym: 2013; 92 40 47
38. Vianna RF L., MVLB Bentley, Ribeiro G. et al. Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability. Int J Pharm: 1998; 167 205 213 (Pubitemid 28341522)
39. Wang Jh, Cai Z. Investigation of inclusion complex of miconazole nitrate with β-cyclodextrin. Carbohydr Polym: 2008; 72 255 260 (Pubitemid 351192020)
40. Williams Iii R. O., Mahaguna V., Sriwongjanya M. Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur J Pharm Biopharm: 1998; 46 355 360 (Pubitemid 29057684)
41. Hexsel C. L., Bangert S. D., Hebert A. A. et al. Current sunscreen issues: 2007 Food and Drug Administration sunscreen labelling recommendations and combination sunscreen/insect repellent products. J Am Acad Dermatol: 2008; 59 316 323
42. Nohynek G. J., Schaefer H. Benefit and Risk of Organic Ultraviolet Filters. Regul Toxicol Pharmacol: 2001; 33 285 299 (Pubitemid 32590816)
43. Urbach F. The historical aspects of sunscreens. J Photochem Photobiol B: Biol: 2001; 64 99 104 (Pubitemid 33133660)